Linnaeus Therapeutics: Funding, Investors & Team (Oct 2026)
Linnaeus Therapeutics is a biotech company in the early stages of development that focuses on discovering and developing small molecule agents that affect cellular differentiation to treat cancer and pigment disorders. Founded in 2016, Linnaeus is a UPstart company affiliated with the University of Pennsylvania's Ridky lab.
Linnaeus Therapeutics has raised $25.6M across 3 funding rounds on record, the most recent an undisclosed round of $22.0M announced in Feb 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Linnaeus Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Linnaeus Therapeutics Funding Rounds
Linnaeus Therapeutics raised $1.6M in an undisclosed round announced in Aug 2024.
7 months later, an undisclosed round of $2.0M was announced in Mar 2025.
11 months later, an undisclosed round of $22.0M was announced in Feb 2026.
Linnaeus Therapeutics Founders and Leadership Team
Contact details for the Linnaeus Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Linnaeus Therapeutics Funding Compared to Other Biotechnology Startups
Linnaeus Therapeutics' latest round of $22.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Linnaeus Therapeutics in Biotechnology and Haddonfield
Companies Similar to Linnaeus Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Linnaeus Therapeutics Funding FAQs
What does Linnaeus Therapeutics do?
Linnaeus Therapeutics is a biotech company in the early stages of development that focuses on discovering and developing small molecule agents that affect cellular differentiation to treat cancer and pigment disorders. Founded in 2016, Linnaeus is a UPstart company affiliated with the University of Pennsylvania's Ridky lab.
How much funding has Linnaeus Therapeutics raised?
Linnaeus Therapeutics has raised $25.6M across 3 rounds on record. The most recent is an undisclosed round of $22.0M announced in Feb 2026.
When did Linnaeus Therapeutics last raise funding?
Linnaeus Therapeutics' most recent funding round on record is an undisclosed round of $22.0M, announced in Feb 2026.
Who founded Linnaeus Therapeutics?
FundedIQ lists Christopher Natale (Founder) at Linnaeus Therapeutics.
Where is Linnaeus Therapeutics headquartered?
Linnaeus Therapeutics is based in Haddonfield, New Jersey, United States.
How many employees does Linnaeus Therapeutics have?
Linnaeus Therapeutics is in the 1-10 employee band.
How does Linnaeus Therapeutics' funding compare to other Biotechnology startups?
Linnaeus Therapeutics' latest round of $22.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Linnaeus Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Linnaeus Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.